A specific genetic difference in a gene called RTP5 -- known to be involved in smell and taste perception -- was linked to a higher risk of early death in patients hospitalized with severe COVID-19, according to a study led by researchers at Harvard T.

Jon LaPook, M.

When Medicare recipient and Commack resident Sylvia Grossbach got COVID-19 while in California in June, she was shocked when she was billed $750 for the anti-COVID medication Paxlovid.